A phase I food-effect study of the ribociclib (LEE011) drug-in-capsule (DiC) formulation in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Jul 2015
At a glance
- Drugs Ribociclib (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- 09 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.